Hangzhou Tigermed Consulting Co., Ltd., a provider of clinical development services across China and Asia Pacific, through its subsidiary Hong Kong Tigermed, Ltd., has entered a definitive agreement to acquire a majority stake in Frontage Laboratories, Inc. for $50.3 million in cash. The acquisition is subject to certain closing conditions and regulatory approval.   Frontage, headquartered in Exton, PA, provides services from discovery through late-stage clinical trials for novel, generic, and c...